All News

July 26, 2023

Nancy Cox receives American Society of Human Genetics Leadership Award

Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics.

By Bill Snyder
July 25, 2023

Signaling pathways in liposarcomas

A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target.

By Leigh MacMillan
July 25, 2023

Vanderbilt Transplant Center reaches new record in number of procedures performed

The Vanderbilt Transplant Center performed a record number of solid organ transplants in fiscal year 2023 (FY 23) — 665 life-saving procedures among its adult and pediatric programs.

By Matt Batcheldor
July 24, 2023

Colin Walsh elected to the International Academy of Health Sciences Informatics

Vanderbilt’s Colin Walsh, MD, MA, was recently elected to the International Academy of Health Sciences Informatics (IAHSI) class of 2023.

By Mia Garchitorena-Scancarelli
Gordon Bernard, MD, right, with Jeff Balser, MD, PhD, and Jennifer Pietenpol, PhD. (p(photo by Erin O. Smith)
July 20, 2023

Reception honors Gordon Bernard’s decades of service and contributions

Gordon Bernard, MD, was honored at a reception on July 19 in recognition of his contributions to Vanderbilt University Medical Center for more than 40 years.

By VUMC News and Communications
July 20, 2023

Predicting gene expression may speed discovery: study

Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.

By Bill Snyder
July 20, 2023

Rare case: brain injury stirs creativity, synesthesia

Vanderbilt researchers report on a musician who acquired synesthesia — a merging of sensations — and improved creativity following a traumatic brain injury.
By Paul Govern
July 19, 2023

Summer program gives high schoolers taste of discovery

Since the Aspirnaut high school summer research internship program was launched in 2009, 334 students from 34 states have participated. To date, nearly 90 of them have gone to earn MD degrees, PhDs, or both.
By Bill Snyder
July 19, 2023

Holowatyj receives National Cancer Institute MERIT Award

Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.
By Tom Wilemon
July 18, 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.
By VUMC News and Communications
July 18, 2023

Alliance for Genomic Discovery FAQs

Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery.
By VUMC News and Communications
July 17, 2023

Alzheimer’s genetic risk tracked across sex, race

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.
By Paul Govern
July 11, 2023

Aspirnaut scientific symposium set for Friday, July 14

The Vanderbilt University Medical Center community is invited to attend a scientific symposium on Friday, July 14, presented by high school participants in the Aspirnaut K-20 STEM pipeline for diversity and wellness.
By Bill Snyder